Graves' disease (GD) is a common organ-specific autoimmune disorder, which is multifactorial and develops in genetically susceptible individuals. We had earlier mapped a susceptibility locus for GD to chromosome 5q31-33 in a linkage study. Here we used tag single-nucleotide polymorphisms (SNPs) to search for genetic variants associated with GD, and examined 19 functional candidate genes in this chromosomal region. We identified 192 polymorphisms by re-sequencing the candidate genes, and selected 51 tagSNPs to genotype in a case-control collection of 1118 south Han Chinese subjects (428 cases and 690 controls). Initial analysis suggested that a non-synonymous SNP rs40401 (P27S) of interleukin 3 (IL3) was associated with GD, and further fine-mapping showed that rs40401, or its perfect proxy SNP rs31480 in the 5 0 flanking region of IL3, fully accounted for the association signal at this locus. We replicated significant association of rs40401 with GD in an independent sample collection of 839 north Han Chinese subjects. A combined analysis revealed strong validation of this association (odds ratio (OR common ) ¼ 1.63, combined P (P comb ) ¼ 4 Â 10 À6 in the Recessive disease model). This study provides convincing evidence that the IL3 gene is a susceptibility locus for GD in the Chinese population.
Introduction
Graves' disease (GD) is one of the most common human autoimmune diseases with recent data showing a prevalence of clinical hyperthyroidism of 0.25-1.09%. 1, 2 GD results from the presence of autoantibodies to the thyroid-stimulating hormone receptor, leading to overactivity of the thyroid gland. We and others have earlier implicated chromosomal region 5q31-33 for contributing to the genetic susceptibility to GD in East-Asian populations. [3] [4] [5] The linkage peak in our earlier linkage analysis was within an approximate 2 cM interval between markers D5S436 and D5S4343. The multipoint LOD scores throughout this interval were more than 3.0, with a maximum multipoint LOD score of 4.12.
It is notable that chromosome 5q31-33 contains numerous gene candidates that may potentially play a role in GD, such as cytokines, growth factors and growth factor receptors. Among these genes, polymorphisms in the interleukin 4 (IL4) and the interleukin 13 (IL13) gene were reported to be associated with GD 6, 7 and some genes demonstrated positive association with other autoimmune disease. It has been hypothesized that common pathogenic mechanisms may be shared among autoimmune diseases, and an allele associated with one of the autoimmune diseases has an increased earlier probability of being associated with another autoimmune disease; 8, 9 therefore, single-nucleotide polymorphisms (SNPs) with convincing association with other autoimmune disease should be good candidates for GD. IL3 encodes a cytokine, and variation at this locus has been an earlier reported association with rheumatoid arthritis, asthma and atopy. 10, 11 In addition, the firmly established Crohn's disease association at IBD5 locus on chromosome 5q31 was a good candidate for GD. 12, 13 Although the identity of the precise causal variant within IBD5 remains unknown, recent reports proposed polymorphisms in SLC22A4 and SLC22A5 as responsible for the IBD5 association. 12, 13 Moreover, SNPs within SLC22A4 were also suggested to be associated with rheumatoid arthritis. 14 At the project's initiation, we selected a total of nineteen genes in the 5q31-33 region to test association with GD, all of which show a strong potential involvement in autoimmune and/or inflammatory diseases. Six known genes located in the region, D5S434-D5S436, were selected, namely LARS, POU4F3, TCERG1, PPP2R2B, DPYSL3 and SPINK1. All these six genes have detectable expression in human thyroid and were implicated in several cellular processes, including apoptosis (LARS and SPINK1), transcription (POU4F3, TCERG1 and PPP2R2B) and signal transduction (DPYSL3 and PPP2R2B), which might be related to GD pathogenesis. The other 13 were located within an interval on chromosome 5q31-33 encompassing about 27 Mb around D5S434-D5S436, namely, IL3, SLC22A4, SLC22A5, IRF1, IL5, IL13, IL4, IL9, GCCR, HLA-HB1, ADRB2, IL12B and IL17B. These 13 genes contain a cluster of cytokine and immune-related genes, and all are excellent biological candidate genes as described below. Cytokines participate in the induction and effector phases of the immune and inflammatory response, and are therefore likely to play a critical role in the development of autoimmune thyroid disease. Then, the seven IL genes were selected. A disturbance in Th1/ Th2 cytokine balance is believed to have a role in GD pathophysiological process. Both IRF1 and ADRB2 had been found to affect Th1/Th2 cytokine balance. 15, 16 GCCR encodes the glucocorticoid receptor, and glucocorticoids are important regulators of immunity and inflammation. 17 HLA-HB1 encodes minor histocompatibility antigen HB-1 and is predominantly expressed by immunological effector cells. SLC22A4 and SLC22A5 had been reported to be associated with Crohn disease and rheumatoid arthritis, which, similar to GD, had the pathogenesis associated with inflammation and autoimmunity. [12] [13] [14] Given that these genes were chosen within a region with evidence for linkage to GD, and on the basis of our current understanding of GD etiopathology, they should be both positional and functional candidates.
This study was initiated before the data from the International HapMap project were available, and therefore our study design consisted of (1) a re-sequencing step in which we re-sequenced the exons, exon/intron boundaries and up to 1 kb of 3 0 and 5 0 flanking sequence of the 19 genes on chromosome 5q31-33 in 48 individuals (24 cases and 24 controls) to determine the linkage disequilibrium (LD) patterns within each of the candidate genes, (2) using the LD information for the selection of tag SNPs that captured the common variation in these genes, (3) an association screen in which the tag SNPs were typed in south Han Chinese population, (4) finemapping the region harboring the SNP with significant evidence of association in the screen, and (5) a replication study in which we typed the SNP having the most significant evidence of association in the north Han Chinese population.
Results
Resequencing and case-control study of 19 genes on 5q31-33 region During the re-sequencing stage, we identified 192 polymorphisms, 49 of which were novel polymorphisms including 10 insertions/deletions. Fifty SNPs had the minor allele frequency o5% and were not included in the subsequent tag SNP selection. From the remaining 142 common SNPs, all with minor allele frequency 45%, we selected 51 tag SNPs with a minimum threshold value of 0.8 for the r 2 parameter. We then genotyped the tag SNPs to test for susceptibility to GD in 428 unrelated affected individuals and 690 unrelated controls sampled from the south Han Chinese population. All tag SNPs genotyped in GD cases and controls were tested for Hardy-Weinberg equilibrium (HWE). One SNP in the ADRB2 (rs1042713) deviated from HWE in cases (P ¼ 0.02) and in the combined cases and controls data (P ¼ 0.003), but was consistent with HWE in controls (P ¼ 0.06). The rest of the SNPs showed no deviation from HWE (P40.05). The overall success rate of genotyping assay was over 95% (Supplementary Table 1 
Fine mapping the LD block harboring IL3
Single-nucleotide polymorphism rs31480 at nt-16 in the 5 0 flanking region of IL3 was identified in perfect LD (r 2 ¼ 1) with rs40401 during the re-sequencing phase, and HapMap Phase II CHB data revealed no other perfect proxies for rs40401. SNP rs40401, together with its perfect proxy rs31480, is part of a block of 60 correlated SNPs that cover approximately 68 kb on the HapMap Phase II CHB data. In an attempt to fine-map the causal variant in the LD block contributing to the observed association with GD, we genotyped seven additional SNPs in the south Han Chinese samples ( Figure 1 ). These SNPs were chosen to tag the 60 SNPs in the LD block containing rs40401 on the basis of data from the HapMap CHB population. No single SNP showed greater significance than rs40401 (Table 2) , and only the SNP rs6596048 showed a suggestive significance (P ¼ 0.04 in multiplicative model, and P ¼ 0.01 in general model). However, stepwise logistic regression analysis showed that rs6596048 no longer reached a statistical significance after conditioning on rs40401 (P40.05). Given the higher LD between rs40401 and rs6596048 (r 2 ¼ 0.95, Figure 1 ), it was highly plausible that this association was because of the strong association at rs40401 with GD susceptibility. These results indicated that rs40401 (or rs31480) fully accounted for the association signal at this locus.
Rs40401 is located in the coding region (C-T at position þ 79) of IL3, resulting in an amino acid change from proline to serine at residue 27 when including the leader sequence, or at residue 8 in the secreted form of human IL-3. There were 34 SNPs in strong LD with rs40401 (r 2 40.95) according to the HapMap Phase II CHB data. All these 34 SNPs were located in an intergenic region centromeric to IL3. Immediately centromeric to the IL3 gene is the acyl-CoA synthetase long-chain member 6 (ACSL6) gene. The ACSL6 and IL3 genes are arranged in a head-to-head orientation, sharing a potential regulatory region of about 46 kb. Among these 34 SNPs, rs3914025 is the nearest SNP to ACSL6 at a distance of about 5 kb. Both rs31480 and these 34 SNPs have the potential possibility to alter the transcription of IL3 or IL3 gene and Graves' disease in Chinese X Chu et al ACSL6. However, earlier study had shown that the two forms of IL3 protein, resulting from the missense SNP rs40401, varied in function; 20 and therefore we focused on this functional association of IL3 in the following analysis.
Replication study
To further confirm this finding, we carried out a validation study with 468 patients and 471 control subjects from Shandong province in northern China. The most strongly associated SNP rs40401 was genotyped by the TaqMan allelic discrimination assays in this northern Han Chinese population. We again obtained an evidence of association between rs40401 and GD with P ¼ 0.0001 in the Recessive disease model; OR ¼ 1.76 (95% confidence interval ¼ 1.32À2.36; Table 1 ), and furthermore, the genetic effect was larger. As we failed to detect any evidence for heterogeneity between the south and north Han Chinese datasets (I 2 ¼ 0%), we combined the data from the two samples. The combined test showed a strong statistical support of an association between rs40401 and GD (P comb ¼ 4 Â 10
À6
; OR common ¼ 1.63, 95% confidence interval ¼ 1.34À1.99 in the Recessive disease model; Table 1 ).
Discussion
Linkage to chromosome 5q31-33 has only been detected in two Asian GD genome screens 3, 4 and has failed to be detected in two Caucasian genome screens. 21, 22 In addition, association analysis using microsatellite markers confirmed evidence for the presence of susceptibility genes in or near 5q23-q33 in a Japanese cohort. 5 This could suggest that these factors are only contributing to GD in the Asian population and not to disease susceptibility in Caucasian populations. Our challenge was to identify the genetic variation responsible for GD susceptibility in the 5q31-33 region, containing about 400 genes. Given the cost limitation to cover such a large chromosomal region, we chose a candidate gene approach. We performed tag SNPs genotyping in the screening cohort, and then used another cohort to confirm preliminary associations. The screening stage of this approach primarily produced the most likely candidates for association with GD among the 19 functional candidate genes analyzed. However, our screening cohort had relatively modest power to confidently discard false negatives. To accommodate this limitation, we relaxed the statistical threshold for suggestive association in our primary screen and did not correct the P-value by multiple testing (Supplementary Table 1 ). Accordingly, we included a built-in replication in our study design to discard false positives as spurious associations. In the screening stage, we Figure 1 Linkage disequilibrium (LD) plots of the 8 tag singlenucleotide polymorphisms (SNPs). These 8 tag SNPs captured 60 SNPs in an LD block harboring the associated SNP, rs40401. We constructed the plots with the program Haploview, 18 and r 2 values ( Â 100) were depicted in the diamonds. r 2 value of 1 represents complete LD, r 2 value greater than 0.8 represents strong LD, r 2 value 0.2-0.8 represents inconclusive LD, and r 2 less than 0.2 represents negligible LD. Blocks were determined by Haploview using the default method of Gabriel et al. P-values for the south and north Chinese sample sets were calculated using w 2 -test and had not been corrected for multiple testing. Combined P-values were determined using Fisher's combined test.
18,19

IL3 gene and Graves' disease in Chinese
X Chu et al obtained preliminary evidence for association of SNP rs41401 in the IL3 gene. Although Bonferroni's correction (considering all 51 tag SNPs as essentially independent) renders this result insignificant, as the initial results were derived from a screen of 51 tag SNPs, the replicated association in a second Chinese case-control set argues against a false-positive error. IL3 is a well-studied cytokine that regulates the proliferation, differentiation, activation and survival of three hematopoietic lineages in bone marrow. Although IL3 was first defined as a colony-stimulating factor (multi-colony-stimulating factor), it is not essential to hemopoiesis, and it may function in vivo predominantly as a proinflammatory cytokine. 23 The cytokine IL3 represents a potential candidate for GD, but its role in the pathogenesis of GD has not been elucidated so far. The functional variation rs40401 in IL3 association with GD susceptibility could be explained in two ways. First, rs40401 leads to a change in amino acid residue 8 from proline to serine and these different forms are available as recombinant proteins (recombinant human IL3/proline 8 (rhIL3/P8) and recombinant human IL3/serine 8 (rhIL3/S8)). Earlier study reported that the rhIL3/S8 form had significantly greater potency than rhIL3/P8 in priming human leukocytes for IL4 release, 20 whereas the absence of IL4 could prevent the development of experimental autoimmune GD in the mice model. 24 Hence, individuals carrying the variant T allele corresponding to rhIL3/S8 may have an overall high activity of IL3 and a high level of IL4 and confer less resistance against the development of GD. This is consistent with the observation in our study that GD patients exhibited a higher prevalence of T allele than did controls. Second, IL3 is the key cytokine for the generation of dendritic cells (DCs) derived from plasmacytoid precursors (DC2) and they elicit T helper 2 (Th2) responses. 25 Moreover, IL3-treated monocyte-derived DC (DC1), a typical T helper 1 (Th1)-inducing APC, shifts Th Cell responses toward a Th2 cytokine pattern. 25 Thus, the activity of IL3 may influence the balance between Th1 cytokines, which promote cellmediated immunity, and Th2 cytokines, which promote humoral immunity. The disturbance of Th1/Th2 cytokine balance is an important factor in the pathogenesis of GD. Whether the activity of the two forms of human IL3 caused by rs4041 differs in the effect on DCs remains to be elucidated experimentally.
Among the 19 candidate genes tested in this study, variants in the IL4 gene and in the IL13 gene were reported to be associated with GD. 6, 7 The IL4 gene promoter polymorphism rs2070874 (C-589T), was reported to be associated with GD from the data of a relatively small Caucasian cohort (n ¼ 236), 6 but was never confirmed through replication in the Asian population. [26] [27] [28] [29] Similarly, claim of association was made for polymorphisms of the IL13 gene (rs1800925, C-1112T and rs20541, G2044A) in a Japanese study, 7 but not in others. 27, [30] [31] [32] We did not find evidence of association with GD for these three polymorphisms in our south Han Chinese cohort (Supplementary Table 1 ). Metaanalysis from the data obtained in the present samples and available from earlier studies did not support associations of these three polymorphisms with GD ( Supplementary Figure 1) . Several reasons may explain the lack of replication of initial putative association result, including allelic heterogeneity, the heterogeneity of phenotypes, true variation in disease association between populations, modifying genetic and/or environmental factors, statistically underpowered small sample sizes and a low earlier probability of obtaining a true result. 33 Several limitations of this study should be pointed out. First, we assessed only the polymorphisms located in or close to exons and known regulatory regions, up to 1 kb of 5 0 flanking sequence in this study. Despite the successful identification of the IL3 gene, it is likely that our focus on potentially functional changes led us to miss real loci in the introns of the candidate genes. Second, the relative modest sample size in the screening stage might not be sufficient enough to detect small genetic effects, although we relaxed the statistical threshold for suggestive association in our primary screen and did not correct the P-value by multiple testing. Our screening sample of 428 cases and 690 controls has 457% power to reject the null hypothesis of no association at Po0.05 for a 5% risk allele with a 1.5 genotype relative risk under a multiplicative model. 34 Therefore, our results could only indicate that the other 18 candidate genes do not exert a substantial influence on GD susceptibility in the Chinese population. A more highly powered study involving thousands of subjects may yet exclude the role of these variants in GD susceptibility. Finally, as IL3 is located in a broad LD region, the role of the neighboring genes could not be excluded by this IL3 gene and Graves' disease in Chinese X Chu et al study, although we had performed a fine mapping of the LD block harboring IL3. In the next step, we will map the area surrounding IL3 to define the boundary of the association signals.
In summary, we presented powerful evidence of IL3 being a GD susceptibility gene, which should be stressed. However, as GD was mapped to the 5q31-33 region only in Asian people, it is imperative that replication study be carried out in both the Asian population and in other populations to determine whether IL3 is an Asianspecific susceptibility gene. In addition, we performed a candidate-gene association study here; therefore, comprehensive association testing of all tagging markers in this region is required to determine whether additional GD-related genes exist in this region.
Materials and methods
Subjects
Two independent groups of GD cases and controls were used in this study. All the subjects were Han Chinese. The screening cohort consisted of 428 cases and 690 controls recruited from Shanghai in southern China, and the replication cohort consisted of 468 cases and 471 controls recruited from Shandong province in northern China. Demographic information for participants involved in this study was summarized in Table 3 . A sample set of 24 GD cases and 24 controls was used for re-sequencing. We genotyped all the tag SNPs of 19 candidate genes located in the 5q31-33 region in the subjects of the south Han Chinese population, whereas the subjects of the north Han Chinese population were used for replication test.
The diagnosis of GD was based on documented clinical and biochemical evidence of hyperthyroidism, diffused goiter and the presence of at least one of the following: positive TSH receptor antibody tests, diffusely increased 131I (iodine-131) uptake in the thyroid gland or presence of exophthalmos. For diagnostic accuracy, all individuals classified as affected were interviewed and examined by experienced clinicians. Information was also collected from the examination of medical records and all other available sources. With informed consent, blood samples were collected from all participants for DNA preparation as well as for biochemical measurements. This project was approved by the Ethical Committee of the Chinese National Human Genome Center at Shanghai for the involvement of human subjects. Genomic DNA was isolated from peripheral blood leukocytes by the FlexiGene DNA Kit (Qiagen, Hilden, Germany).
Identifying polymorphisms
To identify polymorphisms in the 19 genes in 5q31-33, the exons, exon/intron boundaries and up to 1 kb of 3 0 and 5 0 flanking sequence were re-sequenced from DNA samples of 24 GD patients and 24 unaffected individuals. The sequencing reactions were performed using Applied Biosystems BigDye (version 3.1) chemistry (Applied Biosystems, Foster City, CA, USA), and the sequences were resolved using an ABI 3730 Genetic Analyzer (Applied Biosystems). Analyses of the sequence traces were performed following manufacturerrecommended sequencing protocols and were double scored by a second operator.
Tag SNPs selection and genotyping
Among the re-sequencing genotype data, we selected 142 SNPs with minor allele frequency 45%, successful genotyping rate 495% and P40.01 with HWE testing for the evaluation of LD, and we had 51 tag SNPs for further association study. We used the Tagger tool (http://www.broad.mit.edu/mpg/tagger/) to select the tag SNPs within each candidate gene with a minimum threshold value of 0.8 for the r 2 parameter. 35 When there was more than one tag SNP, we either used only the one with the maximum average r 2 , or preferred the SNPs that might be functionally important (for example, nonsynonymous coding region SNPs (cSNPs) or SNPs in known regulatory regions).
Tag SNPs selection for the block harboring the associated SNP rs40401 was performed by Haploview v3.2 on the basis of the genotyping data from the HapMap phaseII CHB. 18 We first identified the LD block harboring SNP rs40401 from the genotyping data from the HapMap phaseII CHB. Then, we selected tag SNPs to capture a total of 60 SNPs in the LD block. Tag SNPs were selected using Haploview with an r 2 threshold of 0.8 and pairwise tagging, and rs40401 was forced in as a tag SNP. 18 Genotyping for the tag SNPs was performed using TaqMan chemistry (Applied Biosystems). All the tag SNPs were ordered as either pre-validated TaqMans Assays-on-Demand or newly designed TaqMans Assaysby-designs (Applied Biosystems). The TaqMans reaction was carried out following the Applied Biosystems standard protocol. Fluorescent emissions were captured using the ABI Prisms 7900HT Sequence Detection System and converted into genotypes using the ABI Prisms SDS 2.0 software package. A duplicate was added to each 96-well sample plate for quality assurance and quality control validation of inter-plate discordance. The data completion rate was 98.5%.
Statistical analysis
Tests for HWE were performed for each SNP separately among case subjects and control subjects with the use of the w 2 -test. Differences in allele (or genotype) frequencies between case subjects and control subjects were tested for each SNP with the use of the w 2 -test. Allelic odds ratios and 95% confidence intervals were estimated on the basis of a multiplicative model and a recessive disease model. We used Fisher's combined P-value to perform a joint analysis across the two sample sets. A Mantel-Haenszel common OR was calculated across the two sample sets. The w 2 -test and OR computation were performed using SPSS 15.0 (SPSS Inc., Chicago, IL, USA). 
